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Abstract
Long interspersed elements, type 1(LINE-1, L1) are the most abundant and only active autonomous
retrotransposons in the human genome. Native L1 elements are inefficiently expressed because of a transcription
elongation defect thought to be caused by high adenosine content in L1 sequences. Previously, we constructed a
highly active synthetic mouse L1 element (ORFeus-Mm), partially by reducing the nucleotide composition bias. As a
result, the transcript abundance of ORFeus-Mm was greatly increased, and its retrotransposition frequency was >
200-fold higher than its native counterpart. In this paper, we report a synthetic human L1 element (ORFeus-Hs)
synthesized using a similar strategy. The adenosine content of the L1 open reading frames (ORFs) was reduced
from 40% to 27% by changing 25% of the bases in the ORFs, without altering the amino acid sequence. By
studying a series of native/synthetic chimeric elements, we observed increased levels of full-length L1 RNA and
ORF1 protein and retrotransposition frequency, mostly proportional to increased fraction of synthetic sequence.
Overall, the fully synthetic ORFeus-Hs has > 40-fold more RNA but is at most only ~threefold more active than its
native counterpart (L1RP); however, its absolute retrotransposition activity is similar to ORFeus-Mm. Owing to the
elevated expression of the L1 RNA/protein and its high retrotransposition ability, ORFeus-Hs and its chimeric
derivatives will be useful tools for mechanistic L1 studies and mammalian genome manipulation.
Background
The human genome is littered with transposable ele-
ment sequences; some are mere fossil records of ancient
insertion events, whereas others remain active. Of these
active elements, the long interspersed elements, type 1
(LINE-1 or L1) remain among the most active, and are
capable of autonomous retrotransposition [1] and of
providing enzymatic activities for the non-autonomous
retrotransposition of short interspersed nucleotide ele-
ments (SINE) such as Alu elements [2]. Full-length ver-
sions of L1 elements are approximately 6 kb long, and
consist of a 5’ (untranslated region) UTR containing an
internal promoter sequence, two open reading frames
(ORFs), ORF1 and ORF2, and a 3’UTR followed by a
poly(A) tail encoded in the DNA [3-8]. The L1 ORF1
protein (ORF1p) is a non-specific nucleic acid binding
protein with nucleic acid chaperone activity [9-12]. The
ORF2 protein (ORF2p) is responsible for the catalytic
activity necessary for retrotransposition, and contains
both endonuclease and reverse transcriptase activities
[13,14].
L1s make up approximately 17% of the human gen-
ome. However, despite their abundance, the replication
and control mechanisms of these elements are poorly
understood, partly because of their low expression levels
of messenger (m)RNA and protein [15]. We have pre-
viously linked inefficient L1 expression to a transcription
elongation defect potentially caused by high adenosine
content in the ORFs. We subsequently constructed a
synthetic L1, termed ORFeus, in which the codons of
both ORFs were synonymously optimized, based on a
mouse L1 protein sequence [16,17]. This element was at
least 200-fold more active for retrotransposition than
the native mouse element L1spa [18].
In this paper, we describe our use of similar techni-
ques to construct a synthetic human L1 (ORFeus-Hs)
element and several synthetic/native chimeric L1 ele-
ments. Although we observed increased levels of L1
mRNA and ORF1p, the levels of L1 retrotransposition,
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assays [1,19], were only increased by a maximum of
about threefold in this element. We discuss various
models to explain the possible restrictions on ORFeus-
Hs activity. Certain chimeric synthetic/native constructs
were higher in activity than the fully synthetic con-
structs, suggesting that recoding may have abolished a
cis element(s) or introduced one or more deleterious
sequences into ORFeus-Hs. Moreover, one of these chi-
meras produced slightly more mRNA and ORF1 protein
compared with ORFeus-Hs. ORFeus- H sr e p r e s e n t sa
valuable tool for studying mechanisms of L1 replication
and control, particularly at the protein level, by provid-
ing nucleic acid and protein markers that can be
detected more easily.
Results
Construction of ORFeus-Hs and the synthetic/native L1
chimeras
The ORFeus-Hs open reading frames were designed
using the same principles used to construct murine
ORFeus, which we now refer to as ORFeus-Mm to dis-
tinguish it from the main topic of this paper; ORFeus-
Mm was referred to as smL1 in the original publication
[16]. The reading frames were recoded to the preferred
codon for each amino acid (that is, 20 codons were
used), except where internal restriction sites were strate-
gically positioned to facilitate assembly of the complete
s y n t h e t i cO R F s( s e eA d d i t i o n a lf i l e1 ,F i g u r eS 1 ) .T h e
synthetic ORFs were fused either to a cytomegalovirus
(CMV) promoter-enhancer with a Kozak signal, the
native L1 5’ UTR promoter, or a combination of both
(see Additional file 1, Figure S2 for sequences of these
segments). These constructs were also tagged with
either enhanced green fluorescent protein (EGFP-AI)
[19] or neomycin (Neo-AI) [1] retrotransposition mar-
kers to monitor retrotransposition frequency.
Finally, because synthetic and native elements showed
distinct retrotransposition frequencies, and to further
study the sequence requirements for L1 retrotransposi-
tion, we made several chimeric L1 elements consisting
of various combinations of native and synthetic L1 ele-
ments (Figure 1; see Additional file 2, Table S1).
Active retrotransposition by ORFeus-Hs and synthetic/
native L1 chimeras
To explore the effects of our sequence manipulations on
the levels of L1 retrotransposition, retrotransposition
frequency was measured using several independent
assays (Table 1). Briefly, the transfected HEK-293T cells
were harvested, and EGFP-positive cells were counted
by fluorescence-activated cell sorting (FACS) analysis.
Retrotransposition levels of the corresponding native L1
sequences with their various promoters (pLD223,
pWA174, pLD143) were used as a reference for the
other constructs (Table 1, row 1).
Interestingly, the construct containing both the
CMV and native L1 promoters exhibited a signifi-
cantly higher percentage of EGFP-positive cells (14%)
than the constructs containing either promoter on its
own (2.8% and 3.8% respectively). As for the partially
synthetic chimeric L1 constructs, retrotransposition
levels appeared to increase as the length of segments
of synthetic L1 sequence increased, regardless of
which promoter was driving transcription (Table 1,
rows 2 to 4). However, when the fully synthetic L1
constructs (pWA163, pWA165, pLD255) were com-
pared with their respective native constructs (pLD223,
pWA174, pLD143), retrotransposition levels were vari-
able (Table 1, row 5). The ORFeus-Hs construct dri-
ven by a CMV promoter alone was about threefold
more active than its native L1 counterpart, whereas
the ORFeus-Hs construct driven by the 5’ UTR pro-
moter alone was only slightly more active (~1.2 times)
than its native L1 counterpart. Perhaps most unex-
pectedly, the ORFeus-Hs construct driven by both the
CMV and 5’ UTR promoters was actually less active
(0.58 times) than its native L1 counterpart. Thus, the
nature of the promoter used strongly influenced the
relative retrotransposition frequency of synthetic ver-
sions of retrotransposons.
Additionally, it is of interest that in all of the compari-
sons, the chimera-B constructs were consistently more
active than their respective fully synthetic L1 constructs
(Table 1, rows 4 & 5). The B chimeras consisted of the
fully synthetic ORF1 and the first three quarters of syn-
thetic ORF2, with the last quarter of ORF2 derived from
the native L1RP element.
Similar trends were observed when a two-step retro-
transposition assay [1] was used, in which the cells
underwent selection for a Neo-AI reporter, after enrich-
ment for a population of plasmid-bearing cells using
puromycin selection (see Additional file 2. Table S2),
indicating that these effects are dependent on intrinsic
aspects of retrotransposition, not on the specific retro-
transposition reporter used.
The 3’ UTR, inter-ORF and constitutive transport elements
are not essential to ORFeus-Hs retrotransposition
We noted that several of the initial synthetic element con-
structs we made had extremely short 3’ UTRs. A portion
of the 3’ UTR is dispensable for (native) human L1 retro-
transposition [1], thus we investigated whether the vir-
tually complete absence of the UTR in these constructs
could explain the modest increase in transposition rates
(relative to the mouse synthetic elements). To test this
theory, we made several constructs in which the full-
length 3’ UTR sequence was restored in the various
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levels (see Additional file 2, Table S2). This alteration did
increase the ORFeus-Hs retrotransposition frequency, but
only by 1.1 to 2 times, compared with the construct with-
out a 3’ UTR (Table 2, rows 2 and 3).
It has also been reported that the last 20 nucleotides
of ORF2 and the first 70 nucleotides of the 3’ UTR con-
tain a constitutive transport element (CTE) that is
important for the export of full-length mRNA to the
cytoplasm [20]. Because this sequence is imbedded
Figure 1 Schematic representation of native, synthetic and chimeric human L1 elements. Three sets of such constructs differing from
each other at the promoter region are illustrated: the first set carries a cytomegalovirus (CMV) promoter and a Kozak (K) signal, the second set
has a dual CMV-L1 5’ untranslated region (UTR) promoter, and the third has a 5’ UTR promoter only. All elements are cloned in a pCEP-Puro
vector backbone. AMP
R = ampicillin resistance gene; B, E, P = restriction sites EcoRI, BamHI and PmlI, respectively, at the junctions in various
chimeras; EBNA-1 = Epstein-Barr nuclear antigen 1 gene permitting extrachromosomal replication; Intron = human gamma globin intron; Marker
= either enhanced green fluorescent protein or neomycin marker; ORF = open reading frame; Puro
R = puromycin resistance gene; SV40pA =
Simian virus 40 polyadenylation signal. Blue = native sequence; purple = synthetic sequence.
Table 1 Retrotransposition frequency of ORFeus-Hs constructs
Construct
a CMV+Kozak
b CMV+ 5” UTR
c 5” UTR
Fully native 2.8 ± 0.1 (1) [pLD223] 14 ± 0.3 (1) [pWA174] 3.8 ± 0.3 (1) [pLD143]
Chimera-P 5.8 ± 0.3 (2.07) [pWA172] 11.2 ± 0.2 (0.8) [pLD224] 5.1 ± 0.1 (1.34) [pLD252]
Chimera-E 8.8 ± 0.5 (3.14) [pWA170] 12.1 ± 0.3 (0.86) [pLD227] 5.4 ± 0.3 (1.42) [pLD253]
Chimera-B 10.8 ± 0.4 (3.85) [pWA176] 14.3 ± 0.6 (1.02) [pLD225] 6.9 ± 0.4 (1.82) [pLD254]
ORFeus-Hs 8.1 ± 0.3 (2.89) [pWA163] 8.1 ± 0.4 (0.58) [pWA165] 4.5 ± 0.2 (1.18) [pLD255]
ORFeus-Mm ND
d 9.2 ± 0.8 (0.66) [pWA125] ND
aFor each construct, its absolute retrotransposition frequency is represented as percentage of enhanced green fluorescence-positive cells, and data are the mean
± SEM of eight independent experiments. The number in the parentheses represents the fold change of retrotransposition frequency relative to native L1RP
(shown in the first row), and the relevant plasmid name is given in square brackets.
bCMV = cytomegalovirus.
cUTR = untranslated region.
dND = not determined.
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Hs, it was a candidate to explain the difference in activ-
ity between chimera B and ORFeus-Hs. We evaluated
the effect of restoring the CTE sequence alone to the
wild-type sequence (synthetic sequence ® native
sequence). We therefore constructed plasmids in which
both the native CTE and 3’ UTR were restored to
ORFeus-Hs. Interestingly, this maneuver actually
reduced retrotransposition slightly (Table 2, rows 2 and
4), suggesting the presence of a sequence in the native
CTE that is slightly inhibitory to retrotransposition by
these constructs. It is important to recognize that the
constructs described here contain introns, and thus they
may be able to exit the nucleus via a mechanism distinct
from that used by native L1 sequences, which do not
normally undergo splicing as part of the retrotransposi-
tion process. Thus, it is formally possible that retrotran-
s p o s i t i o ni nt h ea b s e n c eo fa ni n t r o n - c o n t a i n i n g
reporter would actually depend on these sequences.
Finally, we replaced the native L1 inter-ORF region in
ORFeus-Hs with a randomized version (see Methods).
This randomization modestly increased the retrotran-
sposition frequency of ORFeus (see Additional file 2,
Table S2). Thus, as has been previously reported for
native L1 [21,22], the native inter-ORF region sequence
is also not crucial for retrotransposition of ORFeus-Hs.
Synthetic sequence increases levels of L1 mRNA
We examined differences in transcript levels between
the native L1RP constructs, ORFeus-Hs and the various
semi-synthetic L1 chimeras. HEK-293T cells were trans-
fected with the following vectors, all of which contain
the CMV promoter: native L1RP with (pWA174) and
without (pLD223) a L1 5’ UTR sequence; the three chi-
meras with increasing lengths of synthetic sequence
with (pLD224, pLD227, pLD225) and without (pWA172,
pWA170, pWA176) L1 5’ UTR sequences; and the fully
synthetic ORFeus- H sc o n s t r u c t sw i t h( p W A 1 6 5 )a n d
without (pWA163) L1 5’ UTRs. The cells were harvested
at 24 hours post-transfection and total RNA was
isolated. Levels of EGFP-containing transcripts were
measured by RNA blotting and normalized to control
(acidic ribosomal phosphoprotein P0; ARPP0) transcript
levels (Figure 2). Lanes 1 to 5 show constructs without a
5’ UTR and lanes 6 to 10 show those with a 5’ UTR.
Spliced and unspliced L1 mRNAs can be identified by
their predicted mobilities in both cases. In all cases,
mRNA levels increased monotonically, but not linearly,
with retrotransposition levels. Amounts of the ORFeus-
Hs L1 transcripts (Figure 2, lanes 5 and 10) were
significantly greater than those observed in their native
counterparts (Figure 2, lanes 1 and 6). As the length of
the synthetic segment in the chimeric constructs
increased, so did L1 transcript levels (Figure 2, lanes 2
to 4 and 7 to 9). In addition, chimera B constructs
appeared to have slightly higher transcript levels than
did the fully synthetic ORFeus-Hs constructs (Figure 2,
lanes 9 and 10). Finally, we observed a complex context
effect: the first three constructs (native, chimera P and
chimera E), which had both CMV and L1 5’ UTR pro-
moters, had higher transcript levels than those with a
CMV promoter alone. This may account for the higher
retrotransposition levels observed. By contrast, the last
two plasmids (chimera B and fully synthetic) showed the
opposite effect, with the CMV promoter alone produ-
cing more RNA than the combination of CMV and 5’
UTR (Figure 3).
Increases in ORF1p expression and ORF2 RT activity in
ORFeus-Hs
To determine the effect of our codon optimization on the
levels of protein expression, HEK-293T cells were trans-
fected and harvested as described above. After lysis, cells
were analyzed by SDS-PAGE, transferred to membranes,
a n dp r o b e dw i t ha n t i - O R F 1 pa n t i b o d y( F i g u r e4 A ) .
Similar to the levels of RNA transcripts, levels of ORF1
protein were considerably elevated for the synthetic and
partly synthetic L1s (Figure 4A). The results were quanti-
fied by densitometry (Figure 3). In cells transfected
with the native L1RP constructs (pLD223, pWA174),
Table 2 The 3’ untranslated region and constitutive transport element are not essential to ORFeus-Hs
retrotransposition
Construct
a CMV
b+5” UTR
c CMV+5” UTR+Kozak CMV+Kozak
Fully native 1.0 ± 0.1 [pWA192] ND
d ND
ORFeus-Hs, no 3” UTR 1.7 ± 0.4 [pWA180] 1.6 ± 0.5 [pWA181] 1.9 ± 0.4 [pWA200]
ORFeus-Hs + 3(UTR 2.4 ± 0.7 [pWA184] 2.8 ± 1.2 [pWA185] 2.0 ± 0.7 [pWA182]
ORFeus-Hs +3” UTR + CTE
e 1.1 ± 0.4 [pWA199] 1.1 ± 0.6 [pWA186] 1.3 ± 0.2 [pWA183]
aFor each construct, retrotransposition frequency is Retrotransposition frequencies are represented as fold changes relative to native L1RP [pWA192]. The average
number of G418R colonies wass 157 per 104 cells seeded. Data are the mean ± SE of six independent experiments. Plasmid names are in square brackets.
bCMV = cytomegalovirus.
cUTR = untranslated region.
dND = not determined.
eCTE = constitutive transport element.
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(Figure 4A, lanes 1 and 6). As with RNA, the levels of
ORF1p increased as the length of synthetic sequence was
increased, but the extent of the increase in ORF1 protein
was much less impressive (Figure 4A, lanes 2 to 5 and
7 to 10). The RNA, protein and retrotransposition
increases correlated in terms of whether retrotransposi-
tion increased or decreased in each construct. Notably,
levels of ORF1p from the chimera-B L1 elements
(pWA176 and pLD225) were also slightly higher than
those observed in the fully synthetic ORFeus-Hs elements
(pWA163, pWA165) (Figure 3, Figure 4A).
Immunoblotting for ORF2 protein was not of suffi-
cient quality to allow quantification. Instead, to evaluate
ORF2p activity from ORFeus-Hs, we performed an L1
element amplification protocol (LEAP) [23] using ribo-
nucleoprotein (RNP) prepared from 293T cells trans-
fected with either L1RP (pWA174) or ORFeus-Hs
(pWA165). As little as 0.1 μg RNP prepared from cells
transfected with ORFeus-Hs produced a signal of
strength equal to that produced by 10 μgn a t i v eR N P
(Figure 4B), but native L1 RNP did not produce a visible
signal until at least 5 μgR N Pw a sa d d e d .T or o u g h l y
quantify the reverse transcription (RT) activity in these
two samples, we titrated the ORFeus-Hs RNP down to
0.025 μg per reaction (see Additional file 1, Figure S3)
and compared its activity with that of native L1 RNP.
Approximately 10 μg native L1 RNP contained similar
RT activity to that of ~0.05 μg ORFeus-Hs RNP (see
Additional file 1: Figure S3B). Although this experiment
is only semiquantitative, it is obvious that cells trans-
fected with ORFeus-Hs displayed ORF2 RT activity of at
least two orders of magnitude higher than those trans-
fected with native L1. This activity increase is much
more in line with RNA abundance than ORF1p abun-
d a n c e( s e eb e l o w ) ,a n ds u g g e s t st h a tL 1R N Am a yb e
limiting for RNP activity.
An interesting finding was that although the fold
increases of L1 RNA and protein were all in the same
direction, the magnitude of the increases was dramati-
cally different (Figure 3). Comparing RNA increases
with protein increases, it can readily be seen that in the
chimera B and fully synthetic cases, the increases in
RNA were much larger than the increases in ORF1 pro-
t e i n ,b yaf a c t o ro ff o u rt of i v ei nt h eC M V - o n l yc o n -
structs. The retrotransposition frequency increases did
not correlate well with RNA abundance in terms of fold
increase, but were consistently 1.3 to 2 times larger in
magnitude than the protein increases in the CMV pro-
moter constructs. By contrast, for the CMV/L1 5’ UTR
promoter constructs, there was a larger increase in pro-
tein level than in retrotransposition frequency.
Discussion
The data presented here provide an interesting contrast
between the synthetic versions of human and mouse ret-
rotransposons, ORFeus-Hs and ORFeus-Mm. Our pre-
vious data showed that the generation of ORFeus-Mm
Figure 2 Total RNA analysis of L1 expression. Expression levels of native, partially synthetic, and completely synthetic ORFeus-Hs were
compared in 293T cells. The vectors used were: pLD223, pWA172, pWA170, pWA176, pWA163, pWA174, pLD224, pLD227, pLD225, pWA165. Top,
L1 mRNA expression; note both spliced and unspliced transcripts. Bottom, RNA expression of loading control, ARPP0.
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Page 5 of 12Figure 3 Relative increases in RNA, protein and retrotransposition frequency. (A) Relative increases in RNA, protein and retrotransposition
frequency in the constructs containing CMV only. Chimera B = pWA176; chimera E = pWA170; chimera P = pWA172; native = pLD223; synthetic
= pWA163. (B) Relative increases in RNA, protein and retrotransposition frequency in the constructs containing both CMV and 5’ UTR promoters.
Chimera E = pLD227; chimera B = pLD225; chimera P = pLD224; native = pWA174; synthetic = pWA165. Values of pLD223 and pWA174 were
assigned as control in each group of constructs. Data are mean of a minimum of three independent experiments plus standard error. Blue =
RNA; gray = relative retrotransposition frequency; purple = ORF1p.
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Page 6 of 12Figure 4 Analysis of ORF1 protein expression and relative ORF2 RT activity. (A) The same constructs as in Figure 2 were analyzed. The
vectors used were: pLD223, pWA172, pWA170, pWA176, pWA163, pWA174, pLD224, pLD227, pLD225, pWA165. Top, protein expression of ORF1.
Bottom, protein expression of the tubulin loading control. (B) L1 element amplification protocol (LEAP): assay was performed using
ribonucleoproteins (RNPs) prepared from cells transfected with pWA174 (L1RP) and pWA165 (ORFeus-Hs). The numbers 0, 0.1, 0.2, 0.5, 1, 5 and 10
indicate the amount (μg) of total protein of the RNP prep added to each LEAP reaction. The arrows indicate the mobility of LEAP PCR product.
SuperScript III represents a positive control in which 100 U of SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) was added to
the LEAP reaction.
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sequences that might hamper transcription, resulted in a
highly active element with levels of retrotransposition
that were as much as 200-fold higher than the native
element [16]. These were shown to be in part due to
higher levels of mouse L1 transcripts [15], and presum-
ably correspondingly higher levels of protein products.
However, when similar techniques were attempted in
order to develop a highly active human retrotransposon,
we were only able to increase levels of retrotransposition
by a maximum of two to three times. Contrary to the
findings in mouse L1 elements, the synthetic sequences
did not increase human L1 protein and retrotransposi-
tion levels by the same margin.
Native L1 elements contain premature polyadenylation
sites [15,24] and cryptic splice sites [25] that produce
premature polyadenylateda n ds p l i c e df o r mL 1R N A s .
These isoform RNAs could limit full-length L1 RNA
production or compete for L1-encoded ORFs [25]. In
our recoding process, most or all of these signals were
removed, and this probably contributed to the increased
abundance of full-length L1 RNA (Figure 2, Figure 3).
Although the function of these signals in nature remains
unknown, they are dispensable for L1 retrotransposition
in tissue-culture assays.
One obvious reason that ORFeus-Hs did not increase
retrotransposition frequency by 200 times is that the
native mouse L1 element (L1spa) has much lower activity
than the native human L1RP element [18]. In fact, codon
optimization of both mouse and human L1 elements
increased their retrotransposition abilities to a similar
level (Table 1). This could represent an upper limit of
L1 retrotransposition that can be readily tolerated by tis-
sue-culture cells and/or a rate-limiting step(s) during the
process of retrotransposition. Elevated levels of L1 RNA/
protein and shuttling between nucleus and cytoplasm
m a yh a v eas t r o n ge f f e c to nt he cell, perhaps overload-
ing its full capacity to process L1-RNP retrotransposi-
tion intermediates [26]. Consistent with this, we
observed that cells overexpressing either ORFeus-Mm or
ORFeus-Hs displayed considerably higher sensitivity to
antibiotics than those transfected with native L1s. For
example, HEK-293T cells transfected with ORFeus-Hs
grew more slowly at a concentration of 2 μg/ml puro-
mycin than did cells overexpressing native L1RP (see
Additional file 1, Figure S4). These results are consistent
with studies that reported effects on L1 protein expres-
sion leading to high levels of double-strand breaks and/
or apoptosis and/or cellular senescence [27-30]. It is for-
mally possible that codon optimization changes made in
ORFeus corrected a mutation(s) in a cis element(s) that
hampers retrotransposition efficiency of native L1, but
results from both the study of Han et al. [16] on the
mouse element and the present study on the human
element show that L1 activity increases progressively as
larger proportions of the native sequence are recoded,
consistent with the reported elongation defect.
W en o t e dt h a tt h et h r e es e t so fL 1c o n s t r u c t sd r i v e n
by CMV only, CMV plus 5’ UTR or the 5’ UTR only
had very different trends of retrotransposition frequency
changes. This suggests that different promoters some-
how produce RNAs that are of different ‘quality’.O n e
difference in quality is the structure of the RNA 5’ end;
the CMV promoter fragment also contains the 51 bp
viral 5’ UTR upstream of the L1 ORF1 AUG motif,
whereas the native L1 promoter introduces the native
907 bp L1 5’ UTR in its place. In the double-promoter
construct, there are thought to be two transcription
start sites, one identical to the native site, and one
extended on its 5’ end by the CMV 5’ UTR. We have
not directly examined the relative abundance of these
two RNA forms. Thus, the 5’ UTR sequences differ
between the three types of elements, and it is possible
that the interactions between the 5’ UTRs and the rest
of the RNA sequence influence retrotransposition
efficiency.
Unexpected discrepancies in the increases in RNA
abundance, protein abundance and retrotransposition
f r e q u e n c yw e r en o t e db e t w e e nt h ev a r i o u sc o n s t r u c t s ,
with RNA increasing much more dramatically than pro-
tein, and protein increasing more than retrotransposi-
tion frequency. This suggests that when comparing
native versus synthetic RNA sequences, the latter either
interferes with translational efficiency, decreases stability
of the encoded protein, or both. The larger relative
increase in RNA suggests that the primary effect of the
codon optimization was to improve levels of full-length
L1 mRNA. Because codon optimization is predicted to
increase translational efficiency, it is surprising that pro-
tein levels actually decreased relative to RNA template
abundance. It is formally possible that recoding leads to
enhanced protein degradation. Native codon usage may
provide signals for proper folding of the nascent protein
[31]. Alternatively, if the interaction between the RNA
and the protein to form RNP intermediates is abrogated
in the fully or mostly synthetic elements, any ORF1 pro-
tein that does not get incorporated into RNPs may
become very unstable, potentially explaining the RNA-
protein discrepancy observed here.
Perhaps most surprisingly, we found that changes in
ORF2 sequences in chimera B had a significant effect on
the expression of ORF1p (compare pLD225 and pLD165
in Figure 4). This is consistent with models in which
ORF2 protein, or the RNA sequence encoding it, might
participate in the regulation of ORF1 protein translation
or stability. Finally, although recoding of the human ele-
ment did not produce an increase in retrotransposition
frequency that was as dramatic as with ORFeus-Mm,
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tools for L1 studies, and have the highest retrotransposi-
tion frequency of the available human L1s reported.
Higher levels of full-length L1 mRNA and ORF1p pro-
vide a convenient and rapid marker for the early stages
of the L1 replication cycle by various methods such as
immunofluorescence and immunoprecipitation.
Methods
Plasmid construction
Synthetic human ORF1 and ORF2 sequences were created
by replacing each codon in the human L1 ORFs with
codons favored in strongly expressed human genes, and
introducing strategically placed restriction enzyme sites
using a DNA-shuffling approach [32]. Oligonucleotides
(60-mer) (Integrated DNA Technologies, Coralville, IA,
USA) collectively encoding both strands of ORFeus-Hs
reading frames were used, and gene synthesis and assem-
bly were performed as previously described [16]. Syn-
thetic/native L1 chimeras were assembled by exploiting
various native restriction sites (Figure 1; Additional file 2,
Table S1). The sequence of the inter-ORF region was ran-
domized by counting the number of each base in the
native inter-ORF region. These were then randomized by
selecting that number of each base, using the order of
their occurrence in a famous novel [33] (Table 3).
Cell culture, transfection and retrotransposition assay
Retrotransposition assays with EGFP-AI indicators were
performed in HEK-293T cells. HEK-293T cells (ATCC,
Manassas, VA, USA) were maintained in Dulbecco mod-
ified Eagle medium (DMEM; Invitrogen, Carlsbad, CA,
USA) with 10% fetal bovine serum (FBS) and penicillin/
streptomycin (penicillin, 100 units/ml; streptomycin,
100 μg/ml), and cells were passaged upon confluence.
HEK-293T cells were seeded at 2×10
5 cells per well in
six-well plates and grown overnight. The next day,
transfections were performed with 1 μg plasmid and 2.5
μl transfection reagent (Fugene HD; Roche Applied
Science, Indianapolis, IN, USA) according to the manu-
facturer’s protocol. The day after transfection, cells were
treated with trypsin and transferred to 60 mm plates
with complete medium containing puromycin 1 μg/ml.
After 3 days of puromycin selection, cells were washed
in 1× phosphate-buffered saline (PBS), and kept on ice
before undergoing FACS (FACSCalibur instrument; BD
Biosciences, Sparks, MD, USA), using forward scatter ver-
sus green fluorescence plots. The gating for EGFP-positive
cells was determined by analyzing cells transfected with an
expression plasmid (pCEP-Puro; puromycin-resistant,
EGFP-negative). A minimum of 20,000 cells per sample
were analyzed. Data were analyzed using CellQuest soft-
ware. A minimum of eight independent experiments were
performed for each construct.
Retrotransposition assays with Neo-AI indicators were
performed with HeLa cells. HeLa cells were maintained
in DMEM (Invitrogen, Carlsbad, CA, USA) supplemen-
ted with 10% FBS and penicillin/streptomycin, and were
passaged upon confluence. Cells were seeded at 2.5×10
5
per well in a six-well plate, transfected (FuGene6; Roche
Applied Science, Indianapolis, IN, USA) on the follow-
ing day, and selected by growing with puromycin 2.5
μg/ml for 3 days. For each transfection, three 100 mm
dishes were seeded with 1×10
4 to 4×10
4 cells each
under G418 selection (500 μg/ml) for 10 to 14 days. A
minimum of six independent experiments was per-
formed for each construct. Retrotransposition activity
was normalized to activity of L1RP.
Northern blot assays
Total RNA was purified (RNeasy; Qiagen,Valencia, CA,
USA), then 10 μg RNA was loaded on a 1.2% agarose/
formaldehyde gel, blotted overnight to a nylon mem-
brane (Genescreen plus; Perkin Elmer,Waltham, MA,
Table 3 Sequences used for constructs
Name Sequence 5®’3’
Inter-ORF
a AATGGTTTTATACTCTAATCACTGCTAATTATTTCTTTTATTTGACTAGGCGCGCCCATCATA
b
Primers for probes
EGFP forward (JB13766) ACGTAAACGGCCACAAGTTC
EGFP reverse (JB13767) AAGTCGTGCTGCTTCATGTG
ARPP0 Forward ACTGTGCCAGCCCAGAACAC
ARPP0 Reverse GCAGATGGATCAGCCAAGAAG
LEAP
c
JB11560 GCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTT
JB11564 GCGAGCACAGAATTAATACGACTC
JB14067 GGATCCAGACATGATAAGATACATTGATGA
aSequences between open reading frames.
bSequence obtained by randomizing according to the occurrence of the letters in a famous novel (see Methods).
cL1 element amplification protocol.
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ultraviolet radiation, and baked. Prehybridizations and
hybridizations were both performed in an ultrasensitive
hybridization buffer (ULTRAhyb; Applied Biosystems/
Ambion, Austin, TX, USA) at 42°C. Washes were per-
formed in 2×SSC with 0.1% sodium dodecyl sulfate
(SDS) and in 0.1× SSC with 0.1% SDS. Radioactive sig-
nals were detected with a phosphoimager (Typhoon; GE
Healthcare, Piscataway, NJ, USA) and quantified using
ImageQuant software. Northern probes were first ampli-
fied by PCR, purified in gels [alpha 32P] labeled with TP
(Random Prime-It II Kit, Stratagene, Santa Clara, CA,
USA). Primers (Table 3) were used to amplify the EGFP
and ARPP0 probes.
Immunoblot assays
After the 3-day puromycin selection, the cells were lysed
in buffer (M-PER; Thermo Scientific, Rockford, IL, USA)
and spun in a centrifuge for 15 minutes at 13,000 g to
separate out the cell lysate. The cell lysate (10 μl) was
mixed with 10 μl 2× loading buffer (0.1 mol/l Tris-HCl
pH 6.8, with 4.0% SDS, 20% glycerol, 5% b-mercaptoetha-
nol and 0.2% bromophenol blue), and samples were sepa-
rated in 4% to 20% SDS-PAGE gels. After transfer to
nitrocellulose membranes, membranes were probed with
anti-ORF1p IgY antibody, which had been generated by
immunizing chickens with purified human L1 ORF1p
overexpressed in Escherichia coli and purified from yolks
(Gallus Immunotech Inc,Fergus, ON, Canada). Western
blots were developed with detection reagent (ECL-plus;
GE Healthcare, Piscataway, NJ, USA), detected using an
imaging system (LAS3000 instrument (Fujifilm) and
Image Reader LAS-3000 software) at ‘high’ setting. The
signals in the electronic file were quantified using Multi-
G a u g es o f t w a r e( F u j iF i l m ) ,ap r o g r a mb a s e do nb a n d
density. Only the nonsaturated signals were quantified,
and the background was subtracted. Results were nor-
malized by using the tubulin controls as a reference, and
are presented as fold difference relative to fully native
construct. A total of three western blots were performed,
and a representative blot is shown.
LEAP
LEAP was performed according to Kulpa et al. [23].
Briefly, 293T cells were transfected with pWA174
(L1RP) or pWA165 (ORFeus-Hs), and then selected on
puromycin 1 μg/ml for 2 weeks. On harvest day, ~800
million cells were washed with PBS three times and
then resuspended in 10 ml cold PBS. Cells were pelleted
at 3,000 g for 5 minutes in a swinging bucket rotor,
then lysed with 1 ml buffer (1.5 mmol/l KCl, 2.5 m
mol/l MgCl2, 5 m mol/l Tris-HCl, 1% deoxycholic acid,
1% Triton X-100, 1× protease inhibitor cocktail) for
5 min on ice. The lysate was clarified by centrifugation
at 3,000 g for 5 min at 4°C, and the supernatant was
transferred to an 8.5% to 17% sucrose cushion. The gra-
dient was spun at 39,000 rpm (SW40.1 rotor) (178,000
g) for 2 h at 4°C. The pellet was resuspended in 100 μL
5 mmol/l Tris (pH 7.5) with 1× protease inhibitor, and
with glycerol added to give a final concentration of 50%.
RNP preparations were stored at -80°C.
For the LEAP reaction, various amounts of RNP were
added to 50 μlo f5 0m m o l / lT r i s - H C lp H7 . 5 ,5 0
mmol/l KCl, 5 mmol/l MgCl2, 10 mmol/l dithiothreitol,
0.4 μmmol/l 3’ LEAP primer (JB11560; Table 3),
20 units RNasin, 0.2 mmol/l dNTPs and 0.05% Tween
20, and incubated at 37°C for 1 hour. LEAP reaction
product (1 μL )w a su s e da st e m p l a t ei na5 0μlP C R
assay with 5 μl 10× PCR buffer (Roche Applied Science,
I n d i a n a p o l i s ,I N ,U S A ) ,5μl2 . 5m m o l / ld N T P s ,1μl
each of primers JB11564 (5 μmol/l)and JB14067 primers
(5 μmol/l) (Table 3), and 1 μl FastStart Taq polymerase
(Roche Applied Science, Indianapolis, IN, USA). The
reaction was carried out at with an initial denaturation
at 94°C for 5 min, followed by 35 cycles of 94°C for
30 seconds, 56°C for 30 seconds, and 72°C for 30 sec-
onds, and final extension at 72°C for 7 minutes. An ali-
quot (10 μL) of each PCR product was loaded onto a
1.5% agarose gel. Band density was quantified using
Multi-Gauge software.
Cell viability assay
293T cells were transfected with pWA174 (L1RP),
pLD225 (chimera B) or pWA165 (ORFeus-Hs) in six-
well plates (2 μg L1 plasmid + 10 ng pCAG-eGFP/
40000 cells). The following day, cells were treated with
trypsin, and an equal number of cells were plated in a
96-well plate (~10,000 cells/well) with puromycin 2 μg/
ml, or without puromycin selection. Another portion of
the cells was analyzed by FACS to acquire transfection
efficiency. Two days later, 20 μl cell-viability solution
(CellTiter-Blue
®;P r o m e g a ,M a d i s o n ,W I ,U S A )w a s
added to each well. The plate was incubated at 37°C for
2 hours and then read, using a microplate reader with
an excitation wavelength 550 nm and an emission wave-
length of 600 nm. Relative cell viability is presented as
the ratio of viable puromycin-resistant cells divided by
total viable cells (without puromycin selection). Four
independent transfections were performed for each con-
struct, and all values were normalized to the transfec-
tion efficiency acquired by FACS.
Additional material
Additional file 1: Supplementary Figures 1-4. (1) Alignment of native
human L1RP with ORFeus-Hs. BioEdit was used to create a nucleic acid
alignment of native human L1 and ORFeus-Hs, starting at the ATG of
open reading frame (ORF)1 and ending at the stop codon of ORF2. For
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Page 10 of 12these sequences, the base composition of L1RP is 40% A (1998), 21% C
(1047), 19% G (906), 20% T (967). The base composition of ORFeus-HS is
27% A (1322), 34% C (1648), 27% (1314) G, 12% T (624). L1RP (Genbank
accession number AF148856) was used as the sequence for native
human L1. Identities are marked with asterisks. Start and stop codons of
ORF1 and ORF2, restriction sites used to clone building blocks (MfeI,
BsmBI, AscI, AgeI, BstBI, NruI, XmaI, MluI, NheI, EcoRV, NdeI, ClaI, XhoI) and
make native/synthetic chimeras (PmlI, EcoRI and BamHI) are highlighted
in gray boxes. (2) Alignment of different promoters used in this study.
Kozak sequence and boundaries of cytomegalovirus (CMV) and the 5’
untranslated region (UTR) are highlighted. (3) Quantification of L1
element amplification protocol (LEAP). (A) LEAP was performed using a
ribonucleoprotein (RNP) preparation with the indicated amount, and an
equal amount of PCR product was loaded onto a 1.5% agarose gel. The
arrow indicates the mobility of LEAP PCR product on the gel. (B) The
density of the bands was quantified using the Multi-Gauge program and
plotted as a function of the amount of ORFeus-Hs RNP. A trend line was
drawn using values from lane 3 to lane 6 and the X-axis values from lane
1 to lane 2 (0.03 and 0.05 μg respectively) were calculated based on the
trend line. Blue diamond = data from ORFeus-Hs RNP (lanes 3 to 8); red
triangle = data from L1RP RNP (lanes 1 and 2). X-axis, amount of ORFeus-
Hs RNP in uG; Y-axis, pixel value. (4) Cell-viability assay. Relative cell
viability is presented as the ratio of viable puromycin-resistant cells
divided by total viable cells (without puromycin selection). Four
independent transfections were performed for each construct, and triplet
reading was acquired from each transfection. All values were normalized
to the transfection efficiency acquired by fluorescence-activated cell
sorting, and standard error is shown.
Additional file 2: Supplementary Tables. Tables 1 and 2.
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